Portrait of Priya Subramaniam

Priya Subramaniam

Partner

Washington

psubramaniam@sterling-ghold.com

+1 202 555 0213

Washington DC

Practice areas

Education

  • J.D., Columbia Law School (2003)
  • B.A. Economics, University of Chicago (2000)

Certifications

  • Certified Compliance & Ethics Professional (CCEP)
  • Lean Six Sigma Green Belt

Languages

  • English
  • Hindi
  • Tamil

Priya Subramaniam heads the firm's private equity transactional practice, advising leading buyout funds, growth equity investors, and portfolio companies on acquisitions, add-ons, and exits. Her experience spans a broad range of sectors, with a particular focus on healthcare and technology.

Priya is recognized for her ability to manage complex, multi-jurisdiction transactions under tight timelines, bringing a steady hand to negotiations and an acute commercial sense to documentation.

She is a frequent speaker at Private Equity International conferences and has been featured in the Financial Times for her work on diversity in private equity.

Bar Admissions

  • New York (2004)
  • District of Columbia (2007)

Notable Matters

  • Advised SPAC on $1.1B de-SPAC merger and PIPE financing
  • Negotiated landmark licensing agreement for major streaming platform

Cases

  • United States v. Marshfield Pharmaceuticals, No. 21-cr-00891

Professional

  • Federal Bar Council
  • American Intellectual Property Law Association

Community

  • United Way Young Leaders Council

Board Memberships

  • Advisory Board, Wharton Center for Securities Law
  • Chambers USA – Private Equity, Band 2 (2024)
  • IFLR1000 – Women Leaders (2023)

Articles

  • "Privacy by Design in M&A Due Diligence", IAPP Privacy Advisor (2023)
  • "After Twitter v. Musk: Drafting MAE Clauses That Hold Up", Harvard Bus. L. Rev. (2024)

Presentations

  • Keynote, NYU Securities Law Conference (2023)

Podcasts

  • Guest, "Deal Flow" Podcast, Episode 142 — "Negotiating Earnouts"
Authored by Priya Subramaniam

Recent insights

Apr 17, 2026
9 min read

Private Equity in Healthcare: Navigating the 2025 Regulatory Landscape

Federal and state regulators are taking a closer look at PE investment in healthcare. Our team outlines what sponsors need to know before their next acquisition.